Semaglutide Accepted in Scotland for CV Risk Reduction

The SMC accepted semaglutide for adults with established cardiovascular disease and overweight or obesity, expanding its role beyond weight management.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/semaglutide-accepted-scotland-cv-risk-reduction-2026a1000j6s?src=rss

Author :

Publish date : 2026-06-09 10:52:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Semaglutide Accepted in Scotland for CV Risk Reduction

Study Finds No Link Between Semaglutide and AMD Risk

Novel Tool Predicts Risk for Difficult-To-Treat Depression

Related Posts

NHS Funds Direct Optometrist Referrals to Eye Specialists

CDC Trust Falls Sharply; Watchdog Flags Medicaid Gaps; Drug Targets ‘Ozempic Butt’

Novel Tool Predicts Risk for Difficult-To-Treat Depression

Study Finds No Link Between Semaglutide and AMD Risk

Dinosaur-killing Chicxulub asteroid impact site stayed hot for millions of years

Digital CBT May Help Cut Risk for Depression, Anxiety, EDs

NHS Funds Direct Optometrist Referrals to Eye Specialists

CDC Trust Falls Sharply; Watchdog Flags Medicaid Gaps; Drug Targets ‘Ozempic Butt’

Novel Tool Predicts Risk for Difficult-To-Treat Depression

Semaglutide Accepted in Scotland for CV Risk Reduction

Study Finds No Link Between Semaglutide and AMD Risk

Dinosaur-killing Chicxulub asteroid impact site stayed hot for millions of years

Digital CBT May Help Cut Risk for Depression, Anxiety, EDs

A cosmic case of mistaken identity that can only be solved right now

Categories

Archives